February 22, 2020
CUSP’s chairman discusses the fallout from a North Carolina prescriber being told to surrender his DEA license.
CUSP’s chairman discusses DOJ’s treatment of controlled-medication prescribers in the current climate. “Detailed medical records are the only affordable way for a provider to prove his innocence — or at least make the prosecutor think twice about proceeding with criminal charges.”
In recent years, the DEA has been increasing the number of raids on prescribers. CUSP’s chairman gives more insight into this rising problem.
Based on the assorted promotional claims of cannabidiol (CBD) product marketers, it appears that the truth about CBD’s benefits and risks depends on whom you ask and when.
CUSP’s chairman discusses the Trump Administration’s opioid policies, warning that, unless the Food and Drug Administration changes its course, no new forms of the gold-standard medication for opioid addiction will come to market before 2024.
Three interconnected crises are currently happening in America: substance abuse, mental illness, and mass incarceration. All three can be curtailed by providing inmates with treatment and support during incarceration.
Looking forward to the 2020 campaign cycle and beyond, the United States is facing three large national crises: substance abuse, mental illness, and mass incarceration. All of these can be addressed if we fulfill an obligation required of us not only by the Constitution, but also by compassion and common sense.
Michael Barnes discusses the judicial decision deeming the Affordable Care Act unconstitutional and the potential impacts on consumers and states.
CUSP’s chairman explains that U.S. workers are not benefiting from wage increases because higher health-insurance premiums, deductibles, and copays are driving up U.S. inflation. Congress must implement health insurance reforms to control costs and make sure U.S. consumers can actually get treatments and medications when they need them.